Viewing data from:

ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE

ANDA

ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE | A074988 | JEROME STEVENS PHARMACEUTICALS INC

2 strengths0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Apr 30, 1999	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 385MG;30MG;25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 30, 1999

No patent or exclusivity listings for this strength.

#002 — 770MG;60MG;50MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Apr 30, 1999